In vitro binding assays with His-tagged CEP170 beads and lysates of H1650 or H460 NSCLC cell lysates confirmed that 5 μM CEP peptide selectively inhibited the interaction of CEP170 with endogenous TBK1 (Fig. 7a, upper and lower panels). Here, TBK1 is linked to non-small cell lung carcinoma.